BOHD (psychedelic)

BOHD (psychedelic)
Names
IUPAC name
2-amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
Other names
4-Methyl-2,5-dimethoxy-beta-hydroxyphenethylamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-beta-hydroxyamine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C11H17NO3
Molar mass 211.26 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

BOHD (4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine), is a lesser-known psychedelic drug. It is the beta-hydroxy analog of 2C-D. BOHD was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg, and the duration unknown. BOHD produces a marked drop in blood pressure.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOHD.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

References

  1. Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.

See also


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.